I couldn’t sleep very well last night, and started thinking about the BLA. Yes, NP has been saying for the past few months that it will be completed. I’m not trying to rehash any of this. I was just trying to think what else could possibly be the holdup. This is far fetched I admit, but what if BP is seriously interested in a buyout or major partnership...wouldn’t BP want to submit the BLA for Leronlimab themselves? NP has mentioned in the last several months BP has been sniffing around again possibly showing interest. With the cancer results we’ve posted in January and February this year, coupled with the COVID results we’ve seen in recent weeks, they could’ve gotten real serious, real quick! Again, probably not much if anything to it, but if I’m BP and am ready to BO or partner with a much much smaller biotech, I know that I’m requesting to file the BLA, knowing just by recognition it will get pushed through faster and easier.

However, then the idea of what CYDY is worth pops in my head and then things just get silly and a BO probably won’t happen. LOL